Pine River Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Pine River Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,660	Closed	-$880K	–	822
2014 Q4	$880K	Sell	9,660 -16,085	-62%	-$1.37M	0.01%	546
2014 Q3	$2.05M	Hold	25,745	–	–	0.02%	449
2014 Q2	$2M	Hold	25,745	–	–	0.03%	383
2014 Q1	$2.08M	Buy	+25,745	New	+$2.36M	0.03%	377

Other funds holding PLXP

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

TCM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

PAAMCP

Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

SIP

Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return

Pine River Capital Management's PLXP Position: Q1 2015 in Review

Pine River Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2015, closing a stake of 9,660 shares — an estimated $880K sold.

Pine River Capital Management first reported a position in PLXP in Q1 2014 and held it in 4 quarters. The position peaked at $2.08M in Q1 2014. 20 funds tracked by Wall St. Rank hold PLXP as of Q1 2015.

Pine River Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
Pine River Capital Management sold 9,660 PLx Pharma Inc. Common Stock shares in Q1 2015, an estimated $880K.
Pine River Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 4 quarters.
Pine River Capital Management's PLx Pharma Inc. Common Stock position peaked at $2.08M in Q1 2014.
20 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2015.

Based on Pine River Capital Management's 13F filing for Q1 2015, filed 15 May 2015.